Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | PAN-301-1 |
Synonyms | |
Therapy Description |
PAN-301-1 is a vaccine targeting the human aspartyl/aspartate beta-hydroxylase (HAAH/ASPH) that triggers immune activity against tumor cells overexpressing HAAH (Journal of Clinical Oncology 36, no. 15_suppl, PMID: 32811566). |